Published: 2019-04-29

Comparative study to establish significance of D-dimer, lipid profile and homocysteine level in cases of deep vein thrombosis

Vishal Sharma, Mahendra Bendre, Shahaji Chavan, Sree Ganesh B.


Background: The purpose of the study was to establish the relationship of D-dimer, lipid profile and homocysteine level in deep-vein thrombosis (DVT). The purpose of this study was to assess the value of D-dimer in the detection of early DVT.

Methods: A hospital based comparative study was conducted at Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune with 100 patients to compare the level of D-dimer and lipid profile in cases of Deep Vein Thrombosis (DVT) with healthy controls. The study was carried out with following two groups of 50 patients each: study group       : 50 cases with DVT; control group: 50 healthy controls.

Results: The D-Dimer levels was significantly higher in study group as compared to control group (748.44±93.17 vs. 426.06±78.11 ng/ml) and statistically significant as per student t-test (p<0.05). It was observed that total cholesterol (r=0.714; p<0.05), triglyceride (r=0.534; p<0.05), LDL (r=0.662; p<0.05), HDL (r=0.655; p<0.05), homocysteine (r=0.285; p<0.05) and D-dimer (r=0.368; p<0.05) were strongly and directly correlated with DVT.

Conclusions: In our study most sensitive test for early diagnosis of DVT is D-dimer as it is considered to be useful as a screening test for DVT in hospitalized patients with acute medical diseases/episodes. D-dimer assay is an important preliminary test to detect deep vein thrombosis in post-operative cases. Its extreme sensitivity and high negative predictive value make it an ideal single test to screen patients suspected of having deep vein thrombosis. A negative test rules out deep vein thrombois and a positive test report needs further investigation for its confirmation. In case of increased lipid profile levels, patients are more prone to develop DVT hence there should be regular screening for DVT.


DVT, D-dimer, Lipid profile, Homocysteine

Full Text:



Tapson VF, Hyers TM, Waldo AL, Ballard DJ, Becker RC, Caprini JA, et al. Antithrombotic therapy practices in US hospitals in an era of practice guidelines. Arch Intern Med. 2005;165:1458-64.

Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, et al. For the VIAG in E. (VITAE). Venous thromboembolism (VTE) in Europe: The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007;98:756–64.

Lee AD, Stephen E, Agarwal S, Premkumar P. Venous thrombo-embolism in India. Eur J Vasc Endovasc Surg. 2009;37:482–5.

Guidelines CP. Facilitating Learning and Change in Clinical Care Antithrombotic. Therapy and Prevention of Thrombosis Quick Reference Guide for Physicians Antithrombotic Therapy and Prevention 9th Edition : American College. 2012.

Michiels JJ, Palareti G, de Moerloose P. editors. Fibrin D-dimer testing for venous and arterial thrombotic disease. SeminVasc Med. 2005;5:311–34.

Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methodsand clinical applications. Clin Chem. 1993;39:1764–79.

Weiss N, Keller C, Hoffmann U, Loscalzo J. Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia. Vasc Med. 2003;7:227–39.

Mansoor MA, Ueland PM, Aarsland A. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with homocystinuria. Metabolism. 1993;42:1481–5.

Welch G, Loscalzo J. Homocyteine and atherothrombosis. N Engl J Med. 1998;338:1042–50.

Cattaneo M. Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost. 1999;81:165–76.

Harper PL, Theakston E, Ahmed J, Ockelford P. D-dimer concentration increases with age reducing the clinical value of the D-dimer assay in the elderly. Intern Med J. 2007;37:607–13.

Lee AJ, Fowkes FG, Lowe GD. Determinants of fibrin D-dimer in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol. 1995;15:1094–7.

Al-Zahrani H, Lowe GD, Fowkes FG. Increased fibrin turnover in peripheral arterial disease. Comparison with a population study. Clin Hemorheol. 1992;12:867–72.

Giansante C, Fiotti N, Cattin L, Da Col PG, Calabrese S. Fibrinogen. D-dimer and thrombin-antithrombin complexes in a random population sample. Relationships with other cardiovascular risk factors. Thromb Haemost. 1994;71:581–6.

Hume M. Pulmonary embolism: historical aspects. Arch Surg.1963;87:709–14.

Wood KE. A history of pulmonary embolism and deep venous thrombosis. Crit Care Clin. 2009;25:115–31.

Anning ST. The historical aspects of venous thrombosis. Med Hist. 1957;1:28–37.

Dexter L. The chair and venous thrombosis. Trans. Am Clin Climatol Assoc. 1973;84:1–15.

Goodman LR. In search of venous thromboembolism: the first 2913 years. Am J Roentgenol. 2013;201:W576–81

Hunter J. Observations on the inflammation of the internal coat of veins. Trans SocImprov Med Chir Knowl. 1793;1:18–41

Guyatt G, Akl E. Introduction to the ninth edition: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice. CHEST. 2012;141:48S–52.

Useche JN, de Castro AM, Galvis GE, Mantilla RA, Ariza A. Use of US in the evaluation of patients with symptoms of deep venous thrombosis of the lower extremities. Radiographics. 2008;6:1785-97.